Patent · US Active

Process for purification of Carfilzomib

US10253066B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2015
Grant dateApr 9, 2019
Priority date
Expiry dateDec 1, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/1008
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a process for the purification of Carfilzomib of Formula I that reduces the level of an acetamide impurity of Formula II preferably below 0.10 wt %.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.